AAAAAA

   
Results: 1-16 |
Results: 16
Mephenytoin as a probe for CYP2C19 phenotyping: effect of sample storage, intra-individual reproducibility and occurrence of adverse events
Authors: Tamminga, WJ Wemer, J Oosterhuis, B Wieling, J Touw, DJ de Zeeuw, RA de Leij, LFMH Jonkman, JHG
Citation: Wj. Tamminga et al., Mephenytoin as a probe for CYP2C19 phenotyping: effect of sample storage, intra-individual reproducibility and occurrence of adverse events, BR J CL PH, 51(5), 2001, pp. 471-474
Inhibitory effect of telmisartan on the blood pressure response to angiotensin II challenge
Authors: Stangier, J Su, CAPF van Heiningen, PNM Meinicke, T van Lier, JJ de Bruin, H Tamminga, WJ Jonkman, JHG
Citation: J. Stangier et al., Inhibitory effect of telmisartan on the blood pressure response to angiotensin II challenge, J CARDIO PH, 38(5), 2001, pp. 672-685
An optimized methodology for combined phenotyping and genotyping on CYP2D6and CYP2C19
Authors: Tamminga, WJ Wemer, J Oosterhuis, B Brakenhoff, JPG Gerrits, MGF de Zeeuw, RA de Leij, LFMH Jonkman, JHG
Citation: Wj. Tamminga et al., An optimized methodology for combined phenotyping and genotyping on CYP2D6and CYP2C19, EUR J CL PH, 57(2), 2001, pp. 143-146
Exploring the boundaries of bioanalytical quantitative LC-MS-MS
Authors: Lagerwerf, FM van Dongen, WD Steenvoorden, RJJM Honing, M Jonkman, JHG
Citation: Fm. Lagerwerf et al., Exploring the boundaries of bioanalytical quantitative LC-MS-MS, TRAC-TREND, 19(7), 2000, pp. 418-427
Evaluation of analytical and clinical performance of a dual-probe phenotyping method for CYP2D6 polymorphism and CYP3A4 activity screening
Authors: Wieling, J Tamminga, WJ Sakiman, EP Oosterhuis, B Wemer, J Jonkman, JHG
Citation: J. Wieling et al., Evaluation of analytical and clinical performance of a dual-probe phenotyping method for CYP2D6 polymorphism and CYP3A4 activity screening, THER DRUG M, 22(4), 2000, pp. 486-496
Absorption, metabolism, and excretion of intravenously and orally administered [C-14]telmisartan in healthy volunteers
Authors: Stangier, J Schmidt, J Turck, D Switek, H Verhagen, A Peeters, PAM van Marle, SP Tamminga, WJ Sollie, FAE Jonkman, JHG
Citation: J. Stangier et al., Absorption, metabolism, and excretion of intravenously and orally administered [C-14]telmisartan in healthy volunteers, J CLIN PHAR, 40(12), 2000, pp. 1312-1322
Steady-state pharmacodynamics and pharmacokinetics of warfarin in the presence and absence of telmisartan in healthy male volunteers
Authors: Stangier, J Su, CAPF Hendriks, MGC van Lier, JJ Sollie, FAE Oosterhuis, B Jonkman, JHG
Citation: J. Stangier et al., Steady-state pharmacodynamics and pharmacokinetics of warfarin in the presence and absence of telmisartan in healthy male volunteers, J CLIN PHAR, 40(12), 2000, pp. 1331-1337
The effect of telmisartan on the steady-state pharmacokinetics of digoxin in healthy male volunteers
Authors: Stangier, J Su, CAPF Hendriks, MGC van Lier, JJ Sollie, FAE Oosterhuis, B Jonkman, JHG
Citation: J. Stangier et al., The effect of telmisartan on the steady-state pharmacokinetics of digoxin in healthy male volunteers, J CLIN PHAR, 40(12), 2000, pp. 1373-1379
'High throughput' solid-phase extraction technology and turbo ionspray LC-MS-MS applied to the determination of haloperidol in human plasma
Authors: Hempenius, J Steenvoorden, RJJM Lagerwerf, FM Wieling, J Jonkman, JHG
Citation: J. Hempenius et al., 'High throughput' solid-phase extraction technology and turbo ionspray LC-MS-MS applied to the determination of haloperidol in human plasma, J PHARM B, 20(6), 1999, pp. 889-898
Absorption and mass balance of piperonyl butoxide following an 8-h dermal exposure in human volunteers
Authors: Selim, S Preiss, FJ Gabriel, KL Jonkman, JHG Osimitz, TG
Citation: S. Selim et al., Absorption and mass balance of piperonyl butoxide following an 8-h dermal exposure in human volunteers, TOX LETT, 107(1-3), 1999, pp. 207-217
Clopidogrel, a novel antiplatelet agent, and digoxin: Absence of pharmacodynamic and pharmacokinetic interaction
Authors: Peeters, PAM Crijns, HJMJ Tamminga, WJ Jonkman, JHG Dickinson, JP Necciari, J
Citation: Pam. Peeters et al., Clopidogrel, a novel antiplatelet agent, and digoxin: Absence of pharmacodynamic and pharmacokinetic interaction, SEM THROMB, 25, 1999, pp. 51-54
Multiple-dose pharmacokinetics, safety, and tolerability of bosentan, an endothelin receptor antagonist, in healthy male volunteers
Authors: Weber, C Schmitt, R Birnboeck, H Hopfgartner, G Eggers, H Meyer, J van Marle, S Viischer, HW Jonkman, JHG
Citation: C. Weber et al., Multiple-dose pharmacokinetics, safety, and tolerability of bosentan, an endothelin receptor antagonist, in healthy male volunteers, J CLIN PHAR, 39(7), 1999, pp. 703-714
A comparison of the pharmacokinetics and tolerability of riluzole after repeat dose administration in healthy elderly and young volunteers
Authors: Le Liboux, A Cachia, JP Kirkesseli, S Gautier, JY Guimart, C Montay, G Peeters, PAM Groen, E Jonkman, JHG Wemer, J
Citation: A. Le Liboux et al., A comparison of the pharmacokinetics and tolerability of riluzole after repeat dose administration in healthy elderly and young volunteers, J CLIN PHAR, 39(5), 1999, pp. 480-486
Absorption, metabolism and excretion of a single oral dose of C-14-repaglinide during repaglinide multiple dosing
Authors: van Heiningen, PNM Hatorp, V Nielsen, KK Hansen, KT van Lier, JJ van De Merbel, NC Oosterhuis, B Jonkman, JHG
Citation: Pnm. Van Heiningen et al., Absorption, metabolism and excretion of a single oral dose of C-14-repaglinide during repaglinide multiple dosing, EUR J CL PH, 55(7), 1999, pp. 521-525
CYP2D6 and CYP2C19 activity in a large population of Dutch healthy volunteers: indications for oral contraceptive-related gender differences
Authors: Tamminga, WJ Wemer, J Oosterhuis, B Wieling, J Wilffert, B de Leij, LFMH de Zeeuw, RA Jonkman, JHG
Citation: Wj. Tamminga et al., CYP2D6 and CYP2C19 activity in a large population of Dutch healthy volunteers: indications for oral contraceptive-related gender differences, EUR J CL PH, 55(3), 1999, pp. 177-184
Troglitazone has no effect on red cell mass or other erythropoietic parameters
Authors: Young, MMR Squassante, L Wemer, J van Merle, SP Dogterom, P Jonkman, JHG
Citation: Mmr. Young et al., Troglitazone has no effect on red cell mass or other erythropoietic parameters, EUR J CL PH, 55(2), 1999, pp. 101-104
Risultati: 1-16 |